Susquehanna International Group, LLP Coherus Bio Sciences, Inc. Transaction History
Susquehanna International Group, LLP
- $560 Billion
- Q3 2024
A detailed history of Susquehanna International Group, LLP transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 139,053 shares of CHRS stock, worth $102,899. This represents 0.0% of its overall portfolio holdings.
Number of Shares
139,053
Previous 248,681
44.08%
Holding current value
$102,899
Previous $430,000
66.51%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding CHRS
# of Institutions
135Shares Held
77.9MCall Options Held
40.7KPut Options Held
50.1K-
Black Rock Inc. New York, NY11.8MShares$8.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.3MShares$8.37 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.4MShares$7.7 Million0.3% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY3.04MShares$2.25 Million0.18% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.86MShares$2.11 Million0.0% of portfolio
About Coherus BioSciences, Inc.
- Ticker CHRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,724,600
- Market Cap $57.5M
- Description
- Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...